CESAR
MORIS DE LA TASSA
Catedrático de Universidad
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (8)
2020
-
Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial
JACC: Cardiovascular Interventions, Vol. 13, Núm. 3, pp. 323-331
2017
-
Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study
Journal of the American College of Cardiology, Vol. 70, Núm. 7, pp. 845-853
-
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
Journal of the American College of Cardiology, Vol. 70, Núm. 22, pp. 2752-2763
2010
-
Effect of rosiglitazone on progression of coronary atherosclerosis in patients with type 2 diabetes mellitus and coronary artery disease: The assessment on the prevention of progression by rosiglitazone on atherosclerosis in diabetes patients with cardiovascular history trial
Circulation, Vol. 121, Núm. 10, pp. 1176-1187
2007
2006
-
Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: Results from the Euro Heart Survey on Coronary Revascularization
European Heart Journal, Vol. 27, Núm. 6, pp. 671-678
2005
-
Fluvastatin reduces the 4-year cardiac risk in patients with multivessel disease
International Journal of Cardiology, Vol. 98, Núm. 3, pp. 479-486
-
Management and outcome of patients with established coronary artery disease: The Euro Heart Survey on coronary revascularization
European Heart Journal, Vol. 26, Núm. 12, pp. 1169-1179